The Times Tech Podcast Babson’s David Stein: “Succeeding where Theranos failed”
Dec 15, 2023
David Stein, CEO of Babson Diagnostics, discusses the importance of blood testing, how Babson differs from Theranos, their success, using a tiny amount of blood, fighting against the Theranos effect, and the new age of biological data.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7
Introduction
00:00 • 2min
Theranos, Blood Testing Innovation, and Babson Diagnostics
01:38 • 18min
Maximizing Testing with a Small Container of Blood
19:13 • 4min
Exploring Perspectives on Blood Collection and the Need for Convenience
23:30 • 2min
The Challenges of Developing Medical Diagnostics
25:37 • 14min
Expanding Operations and Fundraising for a Startup
39:21 • 3min
Product Launch, Gratitude, and an Ad
42:32 • 3min